Login / Signup

Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study.

Piero RuggenentiMonica CortinovisAneliya ParvanovaMatias TrilliniIlian P IlievAntonio Carlo BossiAntonio BelvisoMaria C AparicioRoberto TrevisanStefano RotaAnnalisa PernaTobia PeracchiNadia RubisDavide MartinettiSilvia PrandiniFlavio GaspariFabiola CarraraSalvatore De CosmoGiancarlo TonoloRuggero MangiliGiuseppe Remuzzinull null
Published in: PLoS medicine (2021)
EudraCT 2006-005954-62; ClinicalTrials.gov NCT00503152.
Keyphrases
  • combination therapy
  • open label
  • type diabetes
  • study protocol
  • quantum dots
  • squamous cell carcinoma
  • randomized controlled trial
  • living cells
  • phase ii study
  • placebo controlled